Table 3.
Clinical characteristics of AML patients
| Characteristic | Newly diagnosed (n = 28) | Relapsed/refractory (n = 13) | Complete remission (n = 19) |
|---|---|---|---|
| Age, y | |||
| Median | 52 | 53 | 42 |
| Range | 13–78 | 18–69 | 18–68 |
| Male, n (%) | 16 (28) | 7 (13) | 11 (19) |
| WBC, × 109/L | |||
| Median | 7.14 | 2.73 | 4.64 |
| Range | 1.2–263.1 | 1.2–198.4 | 1.05–21.56 |
| HGB, g/L | |||
| Median | 79 | 79 | 118 |
| Range | 3–135 | 32–109 | 66–144 |
| PLT, × 109/L | |||
| Median | 39 | 47 | 174 |
| Range | 5–569 | 8–357 | 128–338 |
| Blast in bone marrow, % | |||
| Median | 77.56 | 44 | 1.57 |
| Range | 13.63–97.00 | 10–91 | 0.36–3.15 |
| FAB classification | |||
| M0 | 0 | 0 | 1 |
| M1 | 2 | 1 | 0 |
| M2 | 3 | 2 | 2 |
| M3 | 0 | 0 | 3 |
| M4 | 1 | 0 | 3 |
| M5 | 14 | 9 | 10 |
| M6 | 0 | 0 | 0 |
| M7 | 0 | 0 | 0 |
| Unclassified | 8 | 1 | 0 |
| Cytogenetics, n (%) | |||
| Normal | 11 | 6 | 15 |
| Abnormal | 13 | 6 | 2 |
| Unknown | 4 | 1 | 2 |
AML acute myeloid leukemia, HGB hemoglobin, PLT platelets, WBC white blood cells, FAB French-American-British classification